Sodium voltage-gated channel alpha subunit 9 mutation in epilepsy

Area of Science:

• Neurogenetics
• Molecular Neurology

Background:

• Voltage-gated sodium channel gene mutations are implicated in human epilepsy syndromes like GEFS+ and DS.
• SCN9A encodes critical sodium transporter proteins involved in neuronal excitability.

Observation:

• A 12-year-old patient presented with infantile-onset generalized epileptic seizures and progressive neurodevelopmental delay.
• Targeted next-generation sequencing identified novel heterozygous mutations: c.4702A>C (p.Asn1568His) in SCN9A and c.65G>A (p.Arg22Gln) in MLC1.

Findings:

• The SCN9A mutation (p.Asn1568His) alters the channel protein's topological domain, impacting excitation and inactivation.
• This case establishes a genetic link between SCN9A variants and progressive myoclonic epilepsy with cognitive impairment.

Implications:

• Provides novel insights into sodium channel dysfunction in epilepsy pathogenesis.
• Expands the spectrum of SCN9A-associated neurological disorders.
• Underscores the importance of genetic testing in complex pediatric epilepsy cases.